Bio Medica Laboratories IPO Review: GMP, Price Band, Dates, Allotment & Valuation Analysis
Updated on 29.05.2026|10:24 AMBio Medica Laboratories Limited is set to launch its Initial Public Offering (IPO). It is a contract manufacturer (B2B) specializing in generic pharmaceutical parenteral formulations such as Liquid and Dry Powder Injections.The public issue will open for subscription on Thursday, May 21, 2026, and close on Monday, May 25, 2026.Through this book-built offering, […]

